179 related articles for article (PubMed ID: 9815574)
1. Neuron-specific hel-N1 and HuD as novel molecular markers of neuroblastoma: a correlation of HuD messenger RNA levels with favorable prognostic features.
Ball NS; King PH
Clin Cancer Res; 1997 Oct; 3(10):1859-65. PubMed ID: 9815574
[TBL] [Abstract][Full Text] [Related]
2. Hu antigens: reactivity with Hu antibodies, tumor expression, and major immunogenic sites.
Manley GT; Smitt PS; Dalmau J; Posner JB
Ann Neurol; 1995 Jul; 38(1):102-10. PubMed ID: 7541976
[TBL] [Abstract][Full Text] [Related]
3. Neural expression profile of Elav-like genes in human brain.
Schramm M; Falkai P; Pietsch T; Neidt I; Egensperger R; Bayer TA
Clin Neuropathol; 1999; 18(1):17-22. PubMed ID: 9988134
[TBL] [Abstract][Full Text] [Related]
4. Expression of Hel-N1 and Hel-N2 in small-cell lung carcinoma.
King PH; Dropcho EJ
Ann Neurol; 1996 May; 39(5):679-81. PubMed ID: 8619556
[TBL] [Abstract][Full Text] [Related]
5. Differential expression of the neuroendocrine genes Hel-N1 and HuD in small-cell lung carcinoma: evidence for down-regulation of HuD in the variant phenotype.
King PH
Int J Cancer; 1997 Aug; 74(4):378-82. PubMed ID: 9291425
[TBL] [Abstract][Full Text] [Related]
6. Identification of novel human neuronal leucine-rich repeat (hNLRR) family genes and inverse association of expression of Nbla10449/hNLRR-1 and Nbla10677/hNLRR-3 with the prognosis of primary neuroblastomas.
Hamano S; Ohira M; Isogai E; Nakada K; Nakagawara A
Int J Oncol; 2004 Jun; 24(6):1457-66. PubMed ID: 15138588
[TBL] [Abstract][Full Text] [Related]
7. DNA vaccination with HuD inhibits growth of a neuroblastoma in mice.
Carpentier AF; Rosenfeld MR; Delattre JY; Whalen RG; Posner JB; Dalmau J
Clin Cancer Res; 1998 Nov; 4(11):2819-24. PubMed ID: 9829748
[TBL] [Abstract][Full Text] [Related]
8. HMGI(Y) and HMGI-C genes are expressed in neuroblastoma cell lines and tumors and affect retinoic acid responsiveness.
Giannini G; Di Marcotullio L; Ristori E; Zani M; Crescenzi M; Scarpa S; Piaggio G; Vacca A; Peverali FA; Diana F; Screpanti I; Frati L; Gulino A
Cancer Res; 1999 May; 59(10):2484-92. PubMed ID: 10344762
[TBL] [Abstract][Full Text] [Related]
9. Genomic organization and mutation analysis of Hel-N1 in lung cancers with chromosome 9p21 deletions.
Cairns P; Okami K; King P; Bonacum J; Ahrendt S; Wu L; Mao L; Jen J; Sidransky D
Cancer Res; 1997 Dec; 57(23):5356-9. PubMed ID: 9393760
[TBL] [Abstract][Full Text] [Related]
10. Detection of microscopic disease: comparing histology, immunocytology, and RT-PCR of tyrosine hydroxylase, GAGE, and MAGE.
Cheung IY; Cheung NK
Med Pediatr Oncol; 2001 Jan; 36(1):210-2. PubMed ID: 11464887
[TBL] [Abstract][Full Text] [Related]
11. TrkA expression in peripheral neuroblastic tumors: prognostic significance and biological relevance.
Shimada H; Nakagawa A; Peters J; Wang H; Wakamatsu PK; Lukens JN; Matthay KK; Siegel SE; Seeger RC
Cancer; 2004 Oct; 101(8):1873-81. PubMed ID: 15386308
[TBL] [Abstract][Full Text] [Related]
12. HuR, a RNA stability factor, is expressed in malignant brain tumors and binds to adenine- and uridine-rich elements within the 3' untranslated regions of cytokine and angiogenic factor mRNAs.
Nabors LB; Gillespie GY; Harkins L; King PH
Cancer Res; 2001 Mar; 61(5):2154-61. PubMed ID: 11280780
[TBL] [Abstract][Full Text] [Related]
13. Autoantibodies against the Hel-N1 RNA-binding protein among patients with lung carcinoma: an association with type I anti-neuronal nuclear antibodies.
Dropcho EJ; King PH
Ann Neurol; 1994 Aug; 36(2):200-5. PubMed ID: 8053656
[TBL] [Abstract][Full Text] [Related]
14. Reevaluation of trkA expression as a biological marker of neuroblastoma by high-sensitivity expression analysis--a study of 106 primary neuroblastomas treated in a single institute.
Hishiki T; Saito T; Terui K; Sato Y; Takenouchi A; Yahata E; Ono S; Nakagawara A; Kamijo T; Nakamura Y; Matsunaga T; Yoshida H
J Pediatr Surg; 2010 Dec; 45(12):2293-8. PubMed ID: 21129533
[TBL] [Abstract][Full Text] [Related]
15. Prognostic significance of the tumor suppressor gene maspin in non-small cell lung cancer.
Hirai K; Koizumi K; Haraguchi S; Hirata T; Mikami I; Fukushima M; Yamagishi S; Kawashima T; Okada D; Shimizu K; Kawamoto M
Ann Thorac Surg; 2005 Jan; 79(1):248-53. PubMed ID: 15620951
[TBL] [Abstract][Full Text] [Related]
16. HuD, a neuronal-specific RNA-binding protein, is a potential regulator of MYCN expression in human neuroblastoma cells.
Ross RA; Lazarova DL; Manley GT; Smitt PS; Spengler BA; Posner JB; Biedler JL
Eur J Cancer; 1997 Oct; 33(12):2071-4. PubMed ID: 9516855
[TBL] [Abstract][Full Text] [Related]
17. Localization of human elav-like neuronal protein 1 (Hel-N1) on chromosome 9p21 by chromosome microdissection polymerase chain reaction and fluorescence in situ hybridization.
Han J; Knops JF; Longshore JW; King PH
Genomics; 1996 Aug; 36(1):189-91. PubMed ID: 8812435
[TBL] [Abstract][Full Text] [Related]
18. HuD, a neuronal-specific RNA-binding protein, is a putative regulator of N-myc pre-mRNA processing/stability in malignant human neuroblasts.
Lazarova DL; Spengler BA; Biedler JL; Ross RA
Oncogene; 1999 Apr; 18(17):2703-10. PubMed ID: 10348344
[TBL] [Abstract][Full Text] [Related]
19. Expression of B-myb in neuroblastoma tumors is a poor prognostic factor independent from MYCN amplification.
Raschellà G; Cesi V; Amendola R; Negroni A; Tanno B; Altavista P; Tonini GP; De Bernardi B; Calabretta B
Cancer Res; 1999 Jul; 59(14):3365-8. PubMed ID: 10416595
[TBL] [Abstract][Full Text] [Related]
20. Expression of the RNA binding proteins, Mel-N1, Mel-N2, and Mel-N3 in adipose cells.
Qi C; Wheeler JA; Pruett A; Pekala PH
Biochem Biophys Res Commun; 2002 Jun; 294(2):329-33. PubMed ID: 12051715
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
